https://www.wikidata.org/wiki/Q36607765
CD40: A cytokine receptor in search of a ligand - Wikidata
scientific article published on July 1, 1990
in search ofcytokine receptorcd40ligandwikidata
https://www.mdanderson.org/newsroom/research-newsroom/ash-2025--researchers-identify-cd40-as-potential-biomarker-for-a-type-of-nodal-T-cell-lymphoma.h00-159781968.html
ASH 2025: Researchers identify CD40 as potential biomarker for a type of nodal T cell lymphoma | UT...
Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in angioimmunoblastic T cell lymphoma (AITL),...
https://www.jci.org/articles/view/7014
JCI - The soluble CD40 ligand sCD154 in systemic lupus erythematosus
cd40 ligandsystemic lupusjcisolubleerythematosus
https://www.rcsb.org/structure/1CZZ
RCSB PDB - 1CZZ: STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40...
STRUCTURE OF TNF RECEPTOR ASSOCIATED FACTOR 2 IN COMPLEX WITH A 17-RESIDUE CD40 PEPTIDE
https://www.rcsb.org/structure/1L0A
RCSB PDB - 1L0A: DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3
DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3
https://www.thermofisher.com/antibody/primary/panther/CD40%20receptor%20binding
CD40 receptor binding Antibodies | Invitrogen
Antibodies for proteins involved in CD40 receptor binding pathways, according to their Panther/Gene Ontology Classification
receptor bindingcd40antibodiesinvitrogen
https://www.ncbi.nlm.nih.gov/Structure/pdb/1ZMS
1ZMS: LMP1 Protein binds to TRAF3 as a structural CD40
Latent membrane protein 1TNF receptor associated factor 3
as almp1proteinbindstraf3
https://www.scirp.org/journal/paperinformation?paperid=54020
Lipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10...
Discover the impact of TLR4 signaling on CD40-activated B10 cell competency. Explore how LPS affects B cell-mediated immunity and inflammation in autoimmune...
cd40 ligand
https://www.semanticscholar.org/topic/Anti-CD40-Monoclonal-Antibody-Chi-Lob-7-4/7085837
Anti-CD40 Monoclonal Antibody Chi Lob 7/4 | Semantic Scholar
An IgG1 chimeric monoclonal antibody agonist of the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. Upon intravenous...
monoclonal antibody7 4cd40chilob
https://www.rcsb.org/structure/1RF3
RCSB PDB - 1RF3: Structurally Distinct Recognition Motifs in Lymphotoxin-B Receptor and CD40 for...
Structurally Distinct Recognition Motifs in Lymphotoxin-B Receptor and CD40 for TRAF-mediated Signaling
https://www.mskcc.org/research-advantage/support/technology/available/next-generation-anti-cd40-agonist-antibody-overcome-resistance-immunotherapy
Next-generation Anti-CD40 Agonist Antibody to Overcome Immunotherapy Resistance | Memorial Sloan...
SUMMARY OF INVENTIONAlthough immunotherapy with immune checkpoint blockade has had a major impact on cancer treatment, over 80% of cancer patients still do not...
next generationagonist antibody
https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2023.1252024/full
Frontiers | CD40 gene polymorphism and its expression in children with Kawasaki disease from North...
Introduction. CD40 gene single nucleotide polymorphisms (SNPs) have been associated with susceptibility and development of coronary artery abnormalities (CAA...
https://www.jci.org/articles/view/44327?key=56347f1f6448c0426b53
JCI - A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for...
https://pmc.ncbi.nlm.nih.gov/articles/PMC20020/
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and...
Increasing evidence supports involvement of inflammation and immunity in atherogenesis. We report here that CD40 ligand (CD40L), an immunoregulatory signaling...
vascular endothelial cells
https://www.news-medical.net/news/20250814/Engineered-CD40-antibody-shrinks-tumors-and-induces-remission.aspx
Engineered CD40 antibody shrinks tumors and induces remission
Aug 14, 2025 - Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise-and induced great disappointment.
engineeredcd40antibodyshrinkstumors
https://www.semanticscholar.org/topic/CD40-Ligand%2C-human/1004710
CD40 Ligand, human | Semantic Scholar
CD40 ligand (261 aa, ~29 kDa) is encoded by the human CD40LG gene. This protein is involved in both binding to CD40 and the modulation of B-cell function.
cd40 ligandhumansemanticscholar
https://www.jci.org/articles/view/7014/pdf
JCI - The soluble CD40 ligand sCD154 in systemic lupus erythematosus
cd40 ligandsystemic lupusjcisolubleerythematosus
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-agonist-monoclonal-antibody-cdx-1140
Definition of anti-CD40 agonist monoclonal antibody CDX-1140 - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition ofmonoclonal antibody
https://www.epo.org/de/boards-of-appeal/decisions/t140975eu1
T 0975/14 (Anti-CD40 and anti-CD20 antibody combination therapy/GENENTECH) vom 23.10.2018
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-chi-lob-7-4
Definition of Anti-CD40 Monoclonal Antibody Chi Lob 7/4 - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
https://pmc.ncbi.nlm.nih.gov/articles/PMC17529/
Crystallographic analysis of CD40 recognition and signaling by human TRAF2 - PMC
Tumor necrosis factor receptor superfamily members convey signals that promote diverse cellular responses. Receptor trimerization by extracellular ligands...
crystallographicanalysiscd40recognition
https://www.biospace.com/apexigen-announces-positive-interim-results-from-phase-2-trial-evaluating-its-cd40-antibody-sotigalimab-in-combination-with-doxorubicin-in-patients-with-liposarcoma
Apexigen Announces Positive Interim Results from Phase 2 Trial Evaluating its CD40 Antibody,...
Nov 14, 2022 - Apexigen, Inc. today announced topline data from an ongoing Phase 2 investigator sponsored trial in collaboration with Columbia University, evaluating...
phase 2 trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC20785/
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and...
Although recombinant adenovirus vectors offer a very efficient means by which to transfer genetic information into cells in vivo, antigen-dependent immunity...
cd40 ligandtransientimmunomodulationanti